Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Griesinger

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Cancer|March 6, 2002
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot studyThomas M Behr, Frank Griesinger, Joachim Riggert, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2026
Multidisciplinary tumor boards (MTBs) and survival Outcomes: Adherence to MTB recommendations in patients with lung cancer treated at two European cancer centers (AdThera-2)Esin Aysel Kandemir, Julia Roeper, Lena Ansmann, et al.
Translational Lung Cancer Research|August 9, 2024
Intracranial response to capmatinib after progression on crizotinib in a patient with <i>MET</i> exon 14 skipping non-small cell lung cancer-a case reportBalázs Jóri, Otto Bundschuh, Markus Falk, et al.
Respiration; International Review of Thoracic Diseases|November 7, 2013
Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancerMichael Kreuter, Johan Vansteenkiste, Felix J F Herth, et al.
Annals of Hematology|March 7, 2007
High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineageChristian Hallermann, Kjell Matthias Kaune, Matthias Kjell Kaune, et al.
Annals of Hematology|March 2, 2011
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescueKarin Hohloch, Carsten Oliver Sahlmann, Vijai J Lakhani, et al.
European Journal of Haematology|June 11, 2005
Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoidesRoland Schroers, York Hildebrandt, Rainer Steffens, et al.
British Journal of Haematology|March 8, 2008
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphomaJorg Basecke, Martina Podleschny, Annegret Becker, et al.
Oncology Research and Treatment|March 25, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted TherapiesFabian Acker, Jingting Luan, Puyan Soltani Germy, et al.
Oncology Research and Treatment|April 4, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell EngagersMarcel Kemper, Puyan Soltani Germy, Fabian Acker, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Cancer|March 6, 2002
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot studyThomas M Behr, Frank Griesinger, Joachim Riggert, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2026
Multidisciplinary tumor boards (MTBs) and survival Outcomes: Adherence to MTB recommendations in patients with lung cancer treated at two European cancer centers (AdThera-2)Esin Aysel Kandemir, Julia Roeper, Lena Ansmann, et al.
Translational Lung Cancer Research|August 9, 2024
Intracranial response to capmatinib after progression on crizotinib in a patient with <i>MET</i> exon 14 skipping non-small cell lung cancer-a case reportBalázs Jóri, Otto Bundschuh, Markus Falk, et al.
Respiration; International Review of Thoracic Diseases|November 7, 2013
Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancerMichael Kreuter, Johan Vansteenkiste, Felix J F Herth, et al.
Annals of Hematology|March 7, 2007
High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineageChristian Hallermann, Kjell Matthias Kaune, Matthias Kjell Kaune, et al.
Annals of Hematology|March 2, 2011
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescueKarin Hohloch, Carsten Oliver Sahlmann, Vijai J Lakhani, et al.
European Journal of Haematology|June 11, 2005
Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoidesRoland Schroers, York Hildebrandt, Rainer Steffens, et al.
British Journal of Haematology|March 8, 2008
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphomaJorg Basecke, Martina Podleschny, Annegret Becker, et al.
Oncology Research and Treatment|March 25, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted TherapiesFabian Acker, Jingting Luan, Puyan Soltani Germy, et al.
Oncology Research and Treatment|April 4, 2024
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell EngagersMarcel Kemper, Puyan Soltani Germy, Fabian Acker, et al.
Pageof 16